Health Economic Evidence of Point-of-Care Testing: A Systematic Review
- PMID: 33405188
- PMCID: PMC8160040
- DOI: 10.1007/s41669-020-00248-1
Health Economic Evidence of Point-of-Care Testing: A Systematic Review
Abstract
Objective: Point-of-care testing (POCT) has become an essential diagnostic technology for optimal patient care. Its implementation, however, still falls behind. This paper reviews the available evidence on the health economic impact of introducing POCT to assess if poor POCT uptake may be related to lacking evidence.
Study design: The Scopus and PubMed databases were searched to identify publications describing a health economic evaluation of a point-of-care (POC) test. Data were extracted from the included publications, including general and methodological characteristics as well as the study results summarized in either cost, effects or an incremental cost-effectiveness ratio. Results were sorted into six groups according to the POC test's purpose (diagnosis, screening or monitoring) and care setting (primary care or secondary care). The reporting quality of the publications was determined using the CHEERS checklist.
Results: The initial search resulted in 396 publications, of which 44 met the inclusion criteria. Most of the evaluations were performed in a primary care setting (n = 31; 70.5%) compared with a secondary care setting (n = 13; 29.5%). About two thirds of the evaluations were on POC tests implemented with a diagnostic purpose (n = 28; 63.6%). More than 75% of evaluations concluded that POCT is recommended for implementation, although in some cases only under specific circumstances and conditions. Compliance with the CHEERS checklist items ranged from 20.8% to 100%, with an average reporting quality of 72.0%.
Conclusion: There were very few evaluations in this review that advised against the implementation of POCT. However, the uptake of POCT in many countries remains low. Even though the evaluations included in this review did not always include the full long-term benefits of POCT, it is clear that health economic evidence across a few dimensions of value already indicate the benefits of POCT. This suggests that the lack of evidence on POCT is not the primary barrier to its implementation and that the low uptake of these tests in clinical practice is due to (a combination of) other barriers. In this context, aspects around organization of care, support of clinicians and quality management may be crucial in the widespread implementation of POCT.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.Ont Health Technol Assess Ser. 2009;9(12):1-114. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074516 Free PMC article.
-
Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.Ont Health Technol Assess Ser. 2021 May 6;21(2):1-125. eCollection 2021. Ont Health Technol Assess Ser. 2021. PMID: 34055110 Free PMC article.
-
Regulation and governance for the implementation and management of point-of-care testing in Australia: a scoping review.BMC Public Health. 2025 Feb 24;25(1):758. doi: 10.1186/s12889-025-21894-2. BMC Public Health. 2025. PMID: 39994584 Free PMC article.
Cited by
-
COVID-19 rapid molecular point-of-care testing is effective and cost-beneficial for the acute care of trauma patients.Eur J Trauma Emerg Surg. 2023 Feb;49(1):487-493. doi: 10.1007/s00068-022-02091-x. Epub 2022 Sep 6. Eur J Trauma Emerg Surg. 2023. PMID: 36066585 Free PMC article.
-
Advancements in nanobiosensor technologies for in-vitro diagnostics to point of care testing.Heliyon. 2024 Nov 9;10(22):e40306. doi: 10.1016/j.heliyon.2024.e40306. eCollection 2024 Nov 30. Heliyon. 2024. PMID: 39624329 Free PMC article. Review.
-
Performance of point-of-care glucose testing for the diagnosis of gestational diabetes in South Africa.Int J Gynaecol Obstet. 2025 Feb;168(2):812-821. doi: 10.1002/ijgo.15914. Epub 2024 Sep 22. Int J Gynaecol Obstet. 2025. PMID: 39306742 Free PMC article.
-
Validation of point-of-care tests used at in-home assessments among older adults in primary care.Scand J Prim Health Care. 2025 Jun;43(2):260-269. doi: 10.1080/02813432.2024.2426162. Epub 2024 Nov 11. Scand J Prim Health Care. 2025. PMID: 39526644 Free PMC article.
-
National survey on availability, use and clinical impact of point-of-care blood analysis systems in Swedish emergency departments.BMC Emerg Med. 2025 Jun 7;25(1):93. doi: 10.1186/s12873-025-01251-7. BMC Emerg Med. 2025. PMID: 40483421 Free PMC article.
References
-
- Sidhu MS, Dellsperger KC. Cardiovascular problems in dialysis patients: impact on survival. Adv Perit Dial. 2010;26:47–52. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous